Crossmark

Real-world neoadjuvant and adjuvant Trastuzumab-containing regimen patterns and their association with survival among patients with operable HER2-positive breast cancer from 2007 to 2021

Crossref DOI link: https://doi.org/10.1007/s10549-024-07552-y

Published Online: 2024-11-22

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Hui

Shen, Chan

Laureano, Jaime J.

Lei, Xiudong

Niu, Jiangong

Giordano, Sharon H.

Chavez-MacGregor, Mariana
Funding

Funding for this research was provided by:

Cancer Prevention and Research Institute of Texas (RP160674)

Susan G. Komen (SAC150061, SAC150061)

Susan G. Komen Foundation (SAC220221)

Breast Cancer Research Foundation (BCRF-22-190)
License Information

Text and Data Mining valid from 2024-11-22

Version of Record valid from 2024-11-22
More Information

Article History

Received: 1 May 2024

Accepted: 5 November 2024

First Online: 22 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below